scholarly article | Q13442814 |
P2093 | author name string | Bing Yang | |
James C Grotta | |||
Sean I Savitz | |||
Sushil Sharma | |||
Jaroslaw Aronowski | |||
Roger Strong | |||
Miranda Brenneman | |||
XiaoPei Xi | |||
P2860 | cites work | Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia | Q35652254 |
The inflammatory response in stroke | Q36692346 | ||
Neurotrophic and growth factor gene expression profiling of mouse bone marrow stromal cells induced by ischemic brain extracts | Q36994899 | ||
Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic | Q37307355 | ||
Insulin-like growth factor I: a potential neuroprotective compound for the treatment of acute ischemic stroke? | Q37386568 | ||
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia | Q39774417 | ||
Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. | Q41522029 | ||
Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor | Q43816335 | ||
A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats | Q44829964 | ||
Apoptosis is not an invariable component of in vitro models of cortical cerebral ischaemia | Q44957768 | ||
Macrophage-induced neurotoxicity is mediated by glutamate and attenuated by glutaminase inhibitors and gap junction inhibitors | Q46614579 | ||
Peroxisome-proliferator-activated receptor-gamma (PPARgamma) activation protects neurons from NMDA excitotoxicity | Q46915873 | ||
Treatment with bone marrow mononuclear cells induces functional recovery and decreases neurodegeneration after sensorimotor cortical ischemia in rats | Q48004173 | ||
Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages | Q48189205 | ||
Inflammation and glial responses in ischemic brain lesions | Q48381768 | ||
IL-10 reduces rat brain injury following focal stroke | Q48401527 | ||
Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. | Q53628210 | ||
Caspase inhibition selectively reduces the apoptotic component of oxygen-glucose deprivation-induced cortical neuronal cell death | Q73561443 | ||
Interleukin-10 inhibits both production of cytokines and expression of cytokine receptors in microglia | Q74658731 | ||
P433 | issue | 13 | |
P921 | main subject | microglia | Q1622829 |
P304 | page(s) | 2869-2876 | |
P577 | publication date | 2010-10-01 | |
P1433 | published in | Journal of Neuroscience Research | Q6295654 |
P1476 | title | Bone marrow mononuclear cells protect neurons and modulate microglia in cell culture models of ischemic stroke | |
P478 | volume | 88 |
Q34360213 | Bone marrow mononuclear cells exert long-term neuroprotection in a rat model of ischemic stroke by promoting arteriogenesis and angiogenesis |
Q35058650 | Bone marrow-derived microglia infiltrate into the paraventricular nucleus of chronic psychological stress-loaded mice |
Q37447090 | Bone marrow-derived mononuclear cells do not exert acute neuroprotection after stroke in spontaneously hypertensive rats |
Q28254272 | CXCR4(+)CD45(-) BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in mice |
Q38109608 | Cell therapies: careful translation from animals to patients |
Q35137635 | Central nervous system agents for ischemic stroke: neuroprotection mechanisms |
Q38101938 | Clinical significance of metallothioneins in cell therapy and nanomedicine |
Q42043958 | Comparison of the therapeutic effects of bone marrow mononuclear cells and microglia for permanent cerebral ischemia |
Q28087451 | Developing Cellular Therapies for Stroke |
Q50466351 | Early transplantation of bone marrow mononuclear cells promotes neuroprotection and modulation of inflammation after status epilepticus in mice by paracrine mechanisms. |
Q31139130 | Effects of bone marrow stromal cell transplantation through CSF on the subacute and chronic spinal cord injury in rats |
Q36689602 | High glucose induces apoptosis and suppresses proliferation of adult rat neural stem cells following in vitro ischemia |
Q36615851 | Histopathological Investigation of Different MCAO Modalities and Impact of Autologous Bone Marrow Mononuclear Cell Administration in an Ovine Stroke Model |
Q89637718 | Immune cell regulation of glia during CNS injury and disease |
Q34392864 | Impact of age on the efficacy of bone marrow mononuclear cell transplantation in experimental stroke |
Q90074677 | Influence of Bone Marrow-Derived Mesenchymal Stem Cell Therapy on Oxidative Stress Intensity in Minimally Conscious State Patients |
Q42395056 | Ischemic stroke may activate bone marrow mononuclear cells to enhance recovery after stroke |
Q38162224 | Microglial responses after ischemic stroke and intracerebral hemorrhage |
Q34618480 | MyD88 is a critical regulator of hematopoietic cell-mediated neuroprotection seen after stroke. |
Q37439541 | Paracrine Mechanisms of Intravenous Bone Marrow-Derived Mononuclear Stem Cells in Chronic Ischemic Stroke |
Q35285073 | Potential benefits of allogeneic bone marrow mesenchymal stem cells for wound healing |
Q28269380 | Preconditioning with VEGF Enhances Angiogenic and Neuroprotective Effects of Bone Marrow Mononuclear Cell Transplantation in a Rat Model of Chronic Cerebral Hypoperfusion |
Q48142151 | Protective Effects of Autologous Bone Marrow Mononuclear Cells After Administering t-PA in an Embolic Stroke Model. |
Q30387946 | Systematic Review and Meta-Analysis of Bone Marrow-Derived Mononuclear Cells in Animal Models of Ischemic Stroke |
Q35404142 | The effect of autologous bone marrow mononuclear cell transplantation on the survival duration in Amyotrophic Lateral Sclerosis - a retrospective controlled study |
Q36318376 | The potential benefit of stem cell therapy after stroke: an update |
Q39228433 | Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells. |
Q41975448 | Various Cell Populations Within the Mononuclear Fraction of Bone Marrow Contribute to the Beneficial Effects of Autologous Bone Marrow Cell Therapy in a Rodent Stroke Model |
Search more.